Here we found that the levels of IL-6 were significantly elevated in the plasma of stage III HCC patients compared with healthy donors and stage I HCC patients, which may partially account for the high frequency of circulating Th17 cells in advanced HCC patients. Here, IL6 is linked to hepatocellular carcinoma.